Outpatient case management in low-income epilepsy patients

Epilepsy Research

Volumn 82, Issue 2-3, 2008, Pages 156-161

  Tatum IV, William O ^a,c   Al Saadi, Sam ^a,c   Orth, Thomas L ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Epilepsy Services of West Central Florida   (United States)

^c TAMPA GENERAL HOSPITAL   (United States)

Author keywords

Case management; Epilepsy; Impact; Outpatient; Quality of life

Indexed keywords

LAMOTRIGINE; LICARBAZEPINE; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ANGER; ARTICLE; CASE MANAGEMENT; CHILD; COST EFFECTIVENESS ANALYSIS; DRUG USE; EMERGENCY CARE; EMPLOYER; EPILEPSY; FEMALE; FOLLOW UP; FRIEND; HEALTH CARE COST; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; SOCIAL DISABILITY;

ADULT; AMBULATORY CARE; ANTICONVULSANTS; CASE MANAGEMENT; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; EPILEPSY; FEMALE; FLORIDA; HUMANS; MALE; MEDICAL ASSISTANCE; MIDDLE AGED; POVERTY; PROGRAM EVALUATION; QUALITY OF LIFE; SOCIAL PROBLEMS;

EID: 56449106303     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.07.017     Document Type: Article

References (28)

1. Bazil C.W. Comprehensive care of the epilepsy patient-control, comorbidity, and cost. Epilepsia 45 Suppl. 6 (2004) 3-12
2. Begley C.E., Annegers J.F., Lairson D.R., Reynolds T.F., and Hauser W.A. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 35 (1994) 1230-1243
3. Begley C.E., Famulari M., Annegers J.F., Lairson D.R., Reynolds T.F., Coan S., Dubinsky S., Newmark M.E., Leibson C., So E.L., and Rocca W.A. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 41 (2000) 342-351
4. Caplan R., Sagun J., Siddarth P., Gurbani S., Koh S., Gowrinathan R., and Sankar R. Social competence in pediatric epilepsy: insights into underlying mechanisms. Epilepsy Behav. 6 (2005) 218-228
5. Ethridge P., and Lamb G.S. Professional nursing case management improves quality, access and costs. Nurs. Manage. 20 (1989) 30-35
6. Friedhoff S.G. Intensive case management of high-risk patients in a family medicine residency setting. J. Am. Board Fam. Pract. 12 (1999) 264-269
7. Frost F.J., Hurley J.S., Petersen H.V., Gunter M.J., and Gause D. A comparison of two methods for estimating the health care costs of epilepsy. Epilepsia 41 (2000) 1020-1026
8. Gillham R.A. Refractory epilepsy: an evaluation of psychological methods in outpatient management. Epilepsia 31 (1990) 427-432
9. Gilliam F., Kuzniecky R., Faught E., Black L., Carpenter G., and Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 38 (1997) 233-236
10. Griffiths R.I., Schrammel P.N., Morris G.L., Wills S.H., Labiner D.M., and Strauss M.J. Payer costs of patients diagnosed with epilepsy. Epilepsia 40 (1999) 351-358
11. Group TCM-CTDS. Closing the gap: effect of diabetes case management on glycemic control among low-income ethnic minority populations: the California Medi-Cal type 2 diabetes study. Diabetes Care 27 (2004) 95-103
12. Haaga D.A. Review: case management in primary health care improves symptoms and drug adherence in people with major depression. Evid. Based Ment. Health 9 (2006) 79
13. Hickey M.L., Cook E.F., Rossi L.P., Connor J., Dutkiewicz C., Hassan S.M., Fay M., Lee T.H., and Fairchild D.G. Effect of case managers with a general medical patient population. J. Eval. Clin. Pract. 6 (2000) 23-29
14. Huston C.J. The role of the case manager in a disease management program. Lippincotts Case Manage. 6 (2001) 222-227
15. Jakovljevic V., and Martinovic Z. Social competence of children and adolescents with epilepsy. Seizure 15 (2006) 528-532
16. Jobst B.C., and Holmes G.L. Prescribing antiepileptic drugs: should patients be switched on the basis of cost?. CNS Drugs 18 (2004) 617-628
17. Kim Y.J., and Soeken K.L. A meta-analysis of the effect of hospital-based case management on hospital length-of-stay and readmission. Nurs. Res. 54 (2005) 255-264
18. Ma J., Lee K.V., Berra K., and Stafford R.S. Implementation of case management to reduce cardiovascular disease risk in the Stanford and San Mateo Heart to Heart randomized controlled trial: study protocol and baseline characteristics. Implement. Sci. 1 (2006) 21
19. Naylor M.D., Brooten D., Campbell R., Jacobsen B.S., Mezey M.D., Pauly M.V., and Schwartz J.S. Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA 281 (1999) 613-620
20. Pearson S.D., Goulart-Fisher D., and Lee T.H. Critical pathways as a strategy for improving care: problems and potential. Ann. Intern. Med. 123 (1995) 941-948
21. Pettitt D.J., Okada Wollitzer A., Jovanovic L., He G., and Ipp E. Decreasing the risk of diabetic retinopathy in a study of case management: the California Medi-Cal Type 2 diabetes study. Diabetes Care 28 (2005) 2819-2822
22. Pulsipher D.T., Seidenberg M., Jones J., and Hermann B. Quality of life and comorbid medical and psychiatric conditions in temporal lobe epilepsy. Epilepsy Behav. 9 (2006) 510-514
23. Selwa L.M., Schmidt S.L., Malow B.A., and Beydoun A. Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy. Epilepsia 44 (2003) 1568-1572
24. Shelton R.C., Golin C.E., Smith S.R., Eng E., and Kaplan A. Role of the HIV/AIDS case manager: analysis of a case management adherence training and coordination program in North Carolina. AIDS Patient Care STDS 20 (2006) 193-204
25. Szaflarski M., Meckler J.M., Privitera M.D., and Szaflarski J.P. Quality of life in medication-resistant epilepsy: the effects of patient's age, age at seizure onset, and disease duration. Epilepsy Behav. 8 (2006) 547-551
26. Tatum IV W.O., Galvez R., Benbadis S., and Carrazana E. New antiepileptic drugs: into the new millennium. Arch. Fam. Med. 9 (2000) 1135-1141
27. Vargas R.B., and Cunningham W.E. Evolving trends in Medical care-coordination for patients with HIV and AIDS. Curr. HIV/AIDS Rep. 3 (2006) 139-143
28. Wilby J., Kainth A., Hawkins N., Epstein D., McIntosh H., McDaid C., Mason A., Golder S., O'Meara S., Sculpher M., Drummond M., and Forbes C. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol. Assess. 9 (2005) 1-157 iii-iv